Understanding receptor pharmacology is key to predicting drug effects and answering Step 1 pharmacology questions. Drugs can act as agonists, antagonists, partial agonists, or inverse agonists, each with distinct effects on potency and efficacy.
Key Concepts
- Efficacy (Emax): The Maximum effect a drug can produce.
- Potency (EC50): Amount of drug required to produce a given effect.
- Competitive antagonists shift the dose–response curve to the right (↓ potency, same efficacy).
- Noncompetitive antagonists lower the efficacy but do not change potency.
- Partial agonists have lower efficacy than full agonists, even at high doses.
- Inverse agonists bind the same receptor but decrease baseline activity.
Graphical Summary
- Competitive Antagonist → Rightward shift (↓ potency, efficacy unchanged).

- Noncompetitive Antagonist → Downward shift (↓ efficacy, potency unchanged).

- Partial Agonist → Reduced efficacy compared to a full agonist.

- Inverse Agonist → Decreases receptor activity below baseline.
Comparison Table
| Type | Potency | Efficacy | Mechanism / Remark | Example |
|---|---|---|---|---|
| Competitive Antagonist | ↓ (reduced) | ↔ (unchanged) | The effect can be overcome by ↑ increasing the agonist concentration | Diazepam (agonist) + Flumazenil (competitive antagonist) at GABA<sub>A</sub> receptor |
| Noncompetitive Antagonist | ↔ (unchanged) | ↓ (reduced) | Cannot be overcome by ↑ an agonist | Norepinephrine (agonist) + Phenoxybenzamine (noncompetitive antagonist) at α-receptors |
| Partial Agonist | Independent | ↓ (lower than a full agonist) | Acts at the same receptor site, but produces a weaker response | Morphine (full agonist) vs Buprenorphine (partial agonist) at μ-opioid receptor |
| Inverse Agonist | Independent | Independent (reduces baseline activity) | Binds constitutively active receptor → opposite effect of agonist | H1 antihistamines (eg, Diphenhydramine) |
Learning Objective :
Be able to differentiate between competitive antagonists, noncompetitive antagonists, partial agonists, and inverse agonists by recognizing their effects on potency and efficacy and applying this knowledge to clinical drug examples.









You must be logged in to post a comment.